CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 1, 1999, Pages 32-36

  Kennedy, M M ^a,e   Biddolph, S ^b   Lucas, S B ^c   Howells, D D ^d   Picton, S ^d   O'D McGee, J ^a   O'Leary, J J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d PE Applied Biosystems   (United Kingdom)

^e BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

CD40; Human herpesvirus 8; Immunohistochemistry; Kaposi's sarcoma; TaqMan polymerase chain reaction

Indexed keywords

CD40 ANTIGEN; CYTOKINE; MEMBRANE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032953117     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.1.32     Document Type: Article

References (37)

1. 1 Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
2. 2 Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995;268:582-3.
3. 3 Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-61.
4. 4 Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345:1043-4.
5. 5 Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch Intern Med 1996;156:202-4.
6. 6 Gao S-J, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-8.
7. 7 Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
8. 8 Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesrus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348:1133-8.
9. 9 Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.
10. 10 Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
11. 11 Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
12. 12 Stürzl M, Roth WK, Brockmeyer NH, et al. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 1992;89:7046-50.
13. 13 Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989;243:223-6.
14. 14 Pammer J, Plettenberg A, Weninger W, et al. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol 1996;148:1387-96.
15. L. Am J Pathol 1996;149:795-803.
16. 16 Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994;76:959-62.
17. 17 Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
18. 18 Karmann K, Hughes CCW, Schechner J, et al. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Prac Natl Acad Sci USA 1995;92:4342-6.
19. 19 Alderson MR, Armitage RJ, Tough TW, et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-74.
20. 20 Neipel F, Albrecht J-C, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997;71:839-42.
21. 21 Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-44.
22. 22 Russo JJ, Bohenzky RA, Chien M-C, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV-8). Proc Natl Acad Sci USA 1996;93:14862-7.
23. 23 Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997;3:287-92.
24. 24 Kennedy MM, Lucas SB, Jones RR, et al. HHV8 and Kaposi's sarcoma: a time cohort study. Mol Pathol 1997;50:96-100.
25. 25 O'Leary JJ, Kennedy MM, Landers RJ, et al. In situ amplification: its application to diagnostic pathology. Current Diagnostic Pathology 1996:2:201-10.
26. 26 Schulz TF, Weiss RA. Kaposi's sarcoma: a finger on the culprit. Nature 1995;373:17-18.
27. 27 Lunardi-Iskandar Y, Gill P, Lam VH, et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst 1995;87:974-81.
28. 28 Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
29. 29 Tuscano JM, Druey KM, Riva A, et al. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 1996;88:1359-64.
30. 30 Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65:1107-15.
31. 31 Wang F, Gregory C, Sample C, et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990;64:2309-18.
32. 32 Zimber-Strobl U, Kempkes B, Marschall G, et al. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J 1996; 15:7070-8.
33. 33 Sarid R, Sato T, Bohenzky RA, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat Med 1997;3:293-8.
34. 34 Kennedy MM, O'Leary JJ, Oates JL, et al. Human herpesvirus 8 (HHV8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression. J Clin Pathol: Mol Pathol 1998;51:155-9.
35. 35 Zhong W, Wang H, Herndier B, et al. Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996;93:6641-6.
36. 36 Merz H, Malisius R, Mannweiler S, et al. Immunomax a maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest 1995;73: 149-56.
37. 37 Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature 1996;382:410.